Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Leonard Meuse"'
Autor:
Hiroyuki Nakai, Michael A. Lochrie, Shangzhen Zhou, Takashi Matsushita, Alan McClelland, Leonard Meuse, Richard T. Surosky, Mark A. Kay, Sally Fuess, Dirk Grimm, Clare E. Thomas, James R. Allen, Peter Colosi, Theresa A. Storm
Publikováno v:
Blood. 102:2412-2419
We report the generation and use of pseudotyped adeno-associated viral (AAV) vectors for the liver-specific expression of human blood coagulation factor IX (hFIX). Therefore, an AAV-2 genome encoding the hfIX gene was cross-packaged into capsids of A
Publikováno v:
Molecular Therapy. 8(4):654-665
Transposon-based vectors represent promising new tools for chromosomal transgene insertion and establishment of persistent gene expression in vivo. Here, we report the development of helper-independent transposon-transposase (HITT) vectors, which con
Autor:
Leonard Meuse, Mark A. Kay, Sally Fuess, Theresa A. Storm, Milton J. Finegold, Markus Grompe, Hiroyuki Nakai, Eugenio Montini
Publikováno v:
Molecular Therapy. 7(1):101-111
Nonviral plasmid DNA is a promising vector for achieving ex vivo and in vivo gene transfer. However, transgene expression is usually transient, especially in dividing target cells due to loss of vector genomes. Here we describe the use of naked doubl
Autor:
Kazuo Ohashi, Peter Sarnow, Leonard Meuse, Shiliang Shen, Anton P. McCaffrey, Peter J. Lukavsky, Alissa M. Lancaster, Mark A. Kay
Publikováno v:
Molecular Therapy. 5:676-684
Hepatitis C virus (HCV) is an RNA virus infecting 1 in every 40 people worldwide. Development of new therapeutics for treating HCV has been hampered by the lack of small-animal models. We have adapted existing hydrodynamic transfection methods to opt
Publikováno v:
Molecular Therapy. 3:403-410
The short duration of transgene expression remains a major obstacle for the implementation of nonviral DNA vectors in clinical gene therapy trials. Here, we demonstrate stable, long-term transgene expression in vivo by transfecting a linear DNA expre
Autor:
Mark A. Kay, Arthur R. Thompson, Xin Ye, Kazuo Ohashi, Gijsbert A. Patijn, Leonard Meuse, Carol H. Miao
Publikováno v:
Molecular Therapy. 1:522-532
We systematically compared human factor IX gene expression from a variety of plasmids containing different cis-regulatory sequences after transfection into different hepatocyte cell lines, or in vivo, after their injection into the livers of mice. Al
Autor:
Ralph H. Schwall, Harry B. Greenberg, Jeffrey S. Glenn, Bruno B. Bordier, Patricia L. Marion, John M. Cullen, Kazuo Ohashi, Leonard Meuse, Hiroyuki Nakai, Mark A. Kay
Publikováno v:
Nature Medicine. 6:327-331
Persistence of hepatocytes transplanted into the same or related species has been established. The long-term engraftment of human hepatocytes into rodents would be useful for the study of human viral hepatitis, where it might allow the species, techn
Autor:
Carol H. Miao, Leonard Meuse, Timothy C. Nichols, Brian A. Donahue, Kenneth M. Brinkhous, Richard O. Snyder, Julie Tubb, Marjorie S. Read, Dwight A. Bellinger, Arthur R. Thompson, Mark A. Kay, Salil Patel, Darrel W. Stafford, Hui Feng Lin
Publikováno v:
Nature Medicine. 5:64-70
Hemophilia B, or factor IX deficiency, is an X-linked recessive disorder occurring in about 1 in 25,000 males. Affected individuals are at risk for spontaneous bleeding into many organs; treatment mainly consists of the transfusion of clotting factor
Publikováno v:
Human Gene Therapy. 9:1449-1456
Recombinant retroviral vectors represent an attractive means of transferring genes into the liver because they integrate in the host cell genome and result in permanent gene expression. However, efficient gene transfer is limited by the requirement o
Autor:
Jeffrey S. Chamberlain, Paul Gregorevic, James M. Allen, Miki Haraguchi, Elina Minami, Eric E. Finn, Michael J. Blankinship, Marvin E. Adams, Leonard Meuse, Stanley C. Froehner, Charles E. Murry
Publikováno v:
Nature Medicine. 12:787-789
Mice carrying mutations in both the dystrophin and utrophin genes die prematurely as a consequence of severe muscular dystrophy. Here, we show that intravascular administration of recombinant adeno-associated viral (rAAV) vectors carrying a microdyst